comparemela.com

Latest Breaking News On - South rampart pharma - Page 3 : comparemela.com

South Rampart Pharma Expands Global Patent Portfolio with EU Approval for FDA Fast-Tracked SRP-001 for Pain

/PRNewswire/ South Rampart Pharma, Inc. ("South Rampart" or the "Company"), a clinical-stage life science company focused on developing innovative pain.

United-states
Canada
Brazil
Russia
Japan
Mexico
India
China
Australia
Hong-kong
Josh-blacher
Hernan-bazan

South Rampart Pharma Receives U.S. FDA Fast Track Designation for SRP-001 for Acute Pain

/PRNewswire/ South Rampart Pharma, Inc. ("South Rampart" or the "Company"), a clinical-stage biopharmaceutical company targeting the safer treatment of.

Josh-blacher
Hernan-bazan
Lotus-clinical-research
Linkedin
Rampart-pharma-inc
Drug-administration
Fast-track
South-rampart-pharma
Accelerated-approval
Priority-review
New-drug-application

South Rampart Pharma to Participate in Upcoming Investor Events

/PRNewswire/ South Rampart Pharma, Inc. ("South Rampart" or the "Company"), a clinical-stage life science company developing SRP-001, a first-in-class.

San-diego
California
United-states
University-of-california-san-francisco
San-francisco
Josh-blacher
Hernan-bazan
Osage-university-partners
Twitter
Novel-analgesic-development-programs
Linkedin
Investor-forum

South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing Phase 1 Clinical Trial

South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing Phase 1 Clinical Trial
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United-states
Hernan-bazan
Josh-blacher
Linkedin
Pharma-inc
Founder-of-lotus-clinical-research
Rampart-pharma-inc
South-rampart
South-rampart-pharma
Neil-singla
Chief-scientific-officer
Lotus-clinical-research

South Rampart Pharma Further Expands Patent Portfolio for SRP-001 with Composition of Matter Patent in China

South Rampart's global intellectual property portfolio now includes granted patents in the United States, China, India, Japan, Australia, Canada, Brazil, Russia, and Mexico NEW ORLEANS, July 6, 2023 /PRNewswire/

India
Australia
Canada
Brazil
Mexico
United-states
China
Russia
Hong-kong
Japan
Chinese
Josh-blacher

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.